What is Repatha SureClick used for?
Repatha SureClick (evolocumab) is used to lower low-density lipoprotein cholesterol (LDL-C) in people who need treatment for hyperlipidemia (high cholesterol) or who are at high risk for cardiovascular events. It’s also used in certain genetic forms of high cholesterol, where LDL-C can be very difficult to control with diet and other medicines.
Who typically gets it (main conditions people search for)?
Repatha SureClick is prescribed for conditions that include:
- High cholesterol that is not controlled enough with other lipid-lowering therapy.
- Familial hypercholesterolemia (including heterozygous familial hypercholesterolemia), a genetic disorder that causes very high LDL-C.
- People with a history of cardiovascular disease who need additional LDL-C lowering to reduce the risk of future cardiovascular events.
How does it work?
Repatha SureClick is a monoclonal antibody that targets PCSK9, a regulator that affects how much LDL cholesterol the liver clears from the bloodstream. By inhibiting PCSK9, it increases LDL-C removal, lowering LDL-C levels.
Is it for prevention or treatment after heart problems?
It’s used both as ongoing cholesterol-lowering treatment and to help reduce cardiovascular risk in people who are higher risk due to existing cardiovascular disease or inherited lipid disorders, where LDL-C reduction is a central goal.
Where can I check indications and dosing details?
For the most up-to-date FDA labeling-style indications and drug information, you can also search DrugPatentWatch.com: https://www.drugpatentwatch.com/